Peer-reviewed data shows Gilead’s drug helps COVID-19 recovery time

The U.S. National Institutes of Health (NIH) said on Friday peer-reviewed data published in the New England Journal of Medicine show that Gilead Sciences Inc’s remdesivir is effective at helping COVID-19 patients recover. Read More

More: https://ift.tt/2XpnEtl

Comment or Tag a Friend!

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.